Aclaris therapeutics appoints jesse hall, m.d. as chief medical officer

Wayne, pa., april 29, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that jesse hall, m.d. has been appointed as chief medical officer.

ACRS Ratings Summary

ACRS Quant Ranking